COVID-19: on the frontline of community pharmacy
Insight into community pharmacy during the COVID-19 pandemic and lockdown. Alongside panic buying of toilet rolls and non-perishables, the March coronavirus lockdown saw patients rushing...
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
How effective data strategies in labs are increasing the throughput of lifesaving drugs
Pietro Forgione of IDBS explains how effective data strategies in labs are increasing the throughput of lifesaving drugs. From R&D contract organisations to large pharmaceutical...
Evolving pharma key account management in a changing NHS
Oli Hudson, Content Director at Wilmington Healthcare, gives an overview of a recent webinar on how pharma key account management must evolve in a...
Graph Databases: The Key to Groundbreaking Medical Research
Neo4j’s Alicia Frame explains how life science researchers can exploit graph databases to get truly granular insight into big data to make major leaps...
Making HCP virtual events a success
David Logue, Senior Vice President of Commercial Strategy at Veeva on how to make HCP virtual events a success. A co-ordinated strategy is critical to...
Medicines and Medical Devices Bill: Getting it right for all
With the Medicines and Medical Devices Bill heading through Parliament, Claudia Rubin asks what is required to get this legislation right? The Government would like...
Does NICE hold the cards to drug pricing and reimbursement?
The upcoming NICE Methods Review begs the question: at what price does a drug represent value for money to the NHS? Rebecca Lanning discusses...
CCG mergers, pharma and integrated care
What does the latest tranche of CCG mergers mean for pharma? Oli Hudson explores the mergers, the role of pharma and the integrated care...
Clinical trials recruitment, engagement & diversity
Kate Shaw, Chief Executive of Innovative Trials, discusses the need to be patient-centred in clinical trials including clinical trials recruitment, engagement and diversity. Top 5...
Latest articles
Elsevier report identifies emerging areas of research in pancreatic cancer
Elsevier has published the findings of a new report on emerging trends in pancreatic cancer research and literature. The report highlights several trending terms...
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre
A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Cost of Russian Sputnik V vaccine for international markets to be less than $10...
The cost of the Russian Sputnik V vaccine for international markets will be less than $10 per dose starting from February 2021, making it...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Virtual clinical trial recruits 67% faster led by NIHR Patient Recruitment Centre
A collaboration between one of the NIHR’s new National Patient Recruitment Centres (NPRCs) and UK sponsor company Enteromed has led to rapid recruitment to...
Top 5 R&D hubs in the UK
Read this cover story in the June issue of Pf Magazine here. Join us on a tour of inspirational research and development centres. ...
Pancreatic Cancer Story: James Dadge
James, 44, lives in Manchester with his partner Andrea and sons Ben and Daniel. He was diagnosed with a neuroendocrine tumour, with the primary...